ASSESSMENT OF THE EFFECTIVENESS OF USE OF INTRANASAL STEROIDS IN PATIENTS CHRONIC RHINOSINUSITIS

Authors
  • Kholov Khusen Negmurodovich

    Bukhara Medical Institute
Abstract

Diseases of the nose and paranasal sinuses (NSS) are among the most common pathologies in otorhinolaryngology, which is facilitated by the modern environmental situation, the widespread prevalence of allergic and viral respiratory diseases, and a decrease in local and general immunity. Most researchers agree that in recent years there has been a tendency in the world to increase the incidence of chronic rhinosinusitis (CRS), including chronic polypous rhinosinusitis (CPRS) [4,5]. Among those turning to an ENT doctor, patients with

References

1. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2)LEN and AllerGen) // Allergy. 2008; 63, Suppl. 86:8–160.

2. Bachert C., Van Cauwenberge P., Olbrecht J., Schoor J.V.Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium // Allergy. 2006; 61:693–698.3. EPOS 2020.Rhinology,vol.58,2020.

3. Slavin RG, Spector SL, Bernstein IL. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005; 116:S13–S47.

4. Valerie J. Lund. Therapeutic Targets in Rhinosinusitis: Infection or Inflammation? Medscape J Med 2008; 10 (4): 105.

5. Keith PK, Scadding GK // Currents Med. Research Opinion. – 2009. – Vol. 25, N 8. – P 2021–2041.

6. Egorova O. A.The choice of intranasal glucocorticosteroid fluticasone propionate (Nazarel) in otorhinolaryngology // Handbook of a polyclinic physician. 2010, no. 3, 67–71.

7. Lopatin A.S., Ivanchenko O.A., Soshnikov S.S. Comparative study of the effectiveness of various treatment regimens for chronic rhinosinusitis. // Russian Rhinology - No. 2 – 2015 – P. 47-56.